SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis
Copyright © 2023. Published by Elsevier B.V..
Viral infection-induced cell death has long been considered as a double-edged sword in the inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 (COVID-19) are characterized by multiple organ dysfunction syndrome and cytokine storm, which may result from SARS-CoV-2-induced cell death. Previous studies have observed enhanced ROS level and signs of ferroptosis in SARS-CoV-2 infected cells or specimens of patients with COVID-19, but the exact mechanism is not clear yet. Here, we find SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. SARS-CoV-2 ORF3a promotes the degradation of NRF2 through recruiting Keap1, thereby attenuating cellular resistance to oxidative stress and facilitated cells to ferroptotic cell death. Our study uncovers that SARS-CoV-2 ORF3a functions as a positive regulator of ferroptosis, which might explain SARS-CoV-2-induced damage in multiple organs in COVID-19 patients and imply the potential of ferroptosis inhibition in COVID-19 treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
---|---|
Enthalten in: |
Redox biology - 63(2023) vom: 15. Juli, Seite 102752 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liu, Lihong [VerfasserIn] |
---|
Links: |
---|
Themen: |
Ferroptosis |
---|
Anmerkungen: |
Date Completed 07.06.2023 Date Revised 15.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.redox.2023.102752 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357475054 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357475054 | ||
003 | DE-627 | ||
005 | 20231226072654.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.redox.2023.102752 |2 doi | |
028 | 5 | 2 | |a pubmed24n1191.xml |
035 | |a (DE-627)NLM357475054 | ||
035 | |a (NLM)37245288 | ||
035 | |a (PII)S2213-2317(23)00153-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liu, Lihong |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.06.2023 | ||
500 | |a Date Revised 15.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
520 | |a Viral infection-induced cell death has long been considered as a double-edged sword in the inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 (COVID-19) are characterized by multiple organ dysfunction syndrome and cytokine storm, which may result from SARS-CoV-2-induced cell death. Previous studies have observed enhanced ROS level and signs of ferroptosis in SARS-CoV-2 infected cells or specimens of patients with COVID-19, but the exact mechanism is not clear yet. Here, we find SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. SARS-CoV-2 ORF3a promotes the degradation of NRF2 through recruiting Keap1, thereby attenuating cellular resistance to oxidative stress and facilitated cells to ferroptotic cell death. Our study uncovers that SARS-CoV-2 ORF3a functions as a positive regulator of ferroptosis, which might explain SARS-CoV-2-induced damage in multiple organs in COVID-19 patients and imply the potential of ferroptosis inhibition in COVID-19 treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Ferroptosis | |
650 | 4 | |a Keap1 | |
650 | 4 | |a NRF2 | |
650 | 4 | |a ORF3a | |
650 | 4 | |a SARS-CoV-2 | |
650 | 7 | |a Kelch-Like ECH-Associated Protein 1 |2 NLM | |
650 | 7 | |a NF-E2-Related Factor 2 |2 NLM | |
650 | 7 | |a KEAP1 protein, human |2 NLM | |
700 | 1 | |a Du, Jie |e verfasserin |4 aut | |
700 | 1 | |a Yang, Sidi |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Birong |e verfasserin |4 aut | |
700 | 1 | |a Shen, Jian |e verfasserin |4 aut | |
700 | 1 | |a Huang, Jiacheng |e verfasserin |4 aut | |
700 | 1 | |a Cao, Liu |e verfasserin |4 aut | |
700 | 1 | |a Huang, Siyao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Xue |e verfasserin |4 aut | |
700 | 1 | |a Guo, Liping |e verfasserin |4 aut | |
700 | 1 | |a Li, Chunmei |e verfasserin |4 aut | |
700 | 1 | |a Ke, Changwen |e verfasserin |4 aut | |
700 | 1 | |a Peng, Xiaofang |e verfasserin |4 aut | |
700 | 1 | |a Guo, Deyin |e verfasserin |4 aut | |
700 | 1 | |a Peng, Hong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Redox biology |d 2013 |g 63(2023) vom: 15. Juli, Seite 102752 |w (DE-627)NLM22743725X |x 2213-2317 |7 nnns |
773 | 1 | 8 | |g volume:63 |g year:2023 |g day:15 |g month:07 |g pages:102752 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.redox.2023.102752 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 63 |j 2023 |b 15 |c 07 |h 102752 |